|
MIER1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.658200E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.504500E-03 |
| Normal-vs-Stage2 |
2.650200E-01 |
| Normal-vs-Stage3 |
3.364400E-03 |
| Normal-vs-Stage4 |
2.38309999999187E-05 |
| Stage1-vs-Stage2 |
6.847800E-01 |
| Stage1-vs-Stage3 |
4.368400E-01 |
| Stage1-vs-Stage4 |
3.078000E-02 |
| Stage2-vs-Stage3 |
4.365200E-01 |
| Stage2-vs-Stage4 |
1.994610E-01 |
| Stage3-vs-Stage4 |
4.266800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.841670E-03 |
| Normal-vs-AfricanAmerican |
1.13310000005029E-06 |
| Normal-vs-Asian |
3.833400E-01 |
| Caucasian-vs-AfricanAmerican |
1.683370E-03 |
| Caucasian-vs-Asian |
8.106300E-02 |
| AfricanAmerican-vs-Asian |
5.001700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.364280E-03 |
| Normal-vs-Female |
2.742600E-03 |
| Male-vs-Female |
9.686000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.489550E-02 |
| Normal-vs-Age(41-60Yrs) |
8.964600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.759490E-03 |
| Normal-vs-Age(81-100Yrs) |
2.701000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.922600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.785800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.730800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.598200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.708500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.229200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.401800E-01 |
| Normal-vs-Grade 2 |
1.230190E-01 |
| Normal-vs-Grade 3 |
1.96147000000035E-05 |
| Normal-vs-Grade 4 |
1.64437999999878E-05 |
| Grade 1-vs-Grade 2 |
9.009000E-01 |
| Grade 1-vs-Grade 3 |
1.505370E-01 |
| Grade 1-vs-Grade 4 |
8.887900E-02 |
| Grade 2-vs-Grade 3 |
3.216200E-03 |
| Grade 2-vs-Grade 4 |
1.939750E-03 |
| Grade 3-vs-Grade 4 |
4.175000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.483200E-01 |
| Normal-vs-ccB subtype |
1.061590E-03 |
| ccA subtype-vs-ccB subtype |
1.235810E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.102000E-03 |
| Normal-vs-N1 |
1.568630E-01 |
| N0-vs-N1 |
9.971000E-01 |
|
|
